Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma

Table 1

Pretreatment hemoglobin levels among clinicopathological and lifestyle factors in lung adenocarcinoma patients, Henan, China, 2017.

	NPHb^1	LPHb^2	value^3
Age (years)
<65	147	24	0.087
≥65	106	29
Sex
Man	118	34	0.020
Women	135	19
TNM^4 stage
I–III	115	19	0.200
IV	138	34
KPS^5
≥80	151	20	0.003
<102	33	60
Lung lobectomy
Yes	77	11	0.157
No	176	42
Chemotherapy
Yes	131	23	0.267
No	122	30
Radiotherapy
Yes	36	5	0.351
No	217	48
Cigarette smoking
No	164	24	0.008
Yes	89	29
Alcohol drinking
No	226	42	0.043
Yes	27	11
Family history of cancer
No	234	50	0.636
Yes	19	3
Survival year
≥1 year	100	32	0.005
<1 year	153	21

¹NPHb (normal pretreatment hemoglobin): men 120–160 g/l and women 110–150 g/l; ²LPHb (low pretreatment hemoglobin): men < 120 g/l and women ≤ 110 g/l). ³Chi-squared (χ²) test. ⁴TNM: tumor-node-metastasis. ⁵KPS: Karnofsky performance status.